Navigation Links
New Heart Ultrasound Research Reveals Life-Saving Treatment Alternatives and Advancements for Heart Patients
Date:6/8/2009

Breakthrough findings unveiled at the American Society of Echocardiography's Scientific Sessions

WASHINGTON, June 8 /PRNewswire/ -- The American Society of Echocardiography (ASE) welcomes the world's leading researchers in cardiovascular medicine to present their most-recent findings at its 20th Annual Scientific Sessions, June 6-10, at the Gaylord National Convention Center in Washington, DC. This year, NBA basketball player and former heart patient, Ronny Turiaf will be in attendance to talk about how echocardiography, otherwise known as heart ultrasound, saved his life.

Many of the studies revealed will have a significant impact on the diagnosis and treatment of heart disease and the application of echocardiograms. Studies detail the following:

  • A nonsurgical option for common heart procedures
  • Lack of adherence to guidelines leave symptoms unidentified and patients untreated
  • Newer technology that can better predict survival chances for heart patients

To view the full text of the press releases and study abstracts, please visit SeeMyHeart.org.

NONSURGICAL OPTION FOR COMMON HEART PROCEDURE OFFERS EFFECTIVE RESULTS WITH LESS RECOVERY TIME FOR PATIENTS

Technique presents options to elderly patients who may not survive open-heart surgery

This study found that patients unable to undergo open-heart surgery may be candidates for a new nonsurgical aortic valve replacement procedure. Transcatheter aortic valve replacement is a promising new treatment for patients with severe aortic stenosis who are considered high risk for conventional surgical aortic valve replacement.

With this approach, echocardiography, or heart ultrasound, is used to guide interventional cardiologists through the procedure and to assess the effects of intervention after the procedure.

"Some people with severe aortic stenosis, or narrowing of the aortic valve, are not good candidates for open-heart surgery because they may have other medical conditions that would classify them as high risk for surgery," said Dr. Linda D. Gillam of the Columbia University Medical Center in New York, a lead author on the study. "These findings are especially critical for elderly patients who could not survive open-heart surgery."

The study concluded that transcatheter and surgical aortic valve replacement result in comparable improvements in radial strain, strain rate and left ventricular ejection fraction in elderly patients with severe symptomatic aortic stenosis.

LACK OF ADHERENCE TO GUIDELINES FOR SEVERE AORTIC STENOSIS LEAVE SYMPTOMS UNIDENTIFIED AND PATIENTS WITH LIFE-THREATENING HEART CONDITIONS UNTREATED

More than 75 percent of patients studied did not have aortic valve replacement surgery even though they met established criteria

Symptoms of severe aortic stenosis are under-diagnosed, preventing patients from receiving potentially life-saving aortic valve replacement surgery, according to research unveiled at ASE's Scientific Sessions. By using cardiovascular ultrasound and other objective tests, physicians can more accurately diagnose symptoms of severe aortic stenosis and help prevent the rapid progression of the disease.

For this research, physicians examined 106 patients and found that only 25 percent with severe aortic stenosis (AS) were referred for surgery. The other 75 percent did not have valve replacement (AVR) surgery even though they met echocardiographic criteria.

"Patients are not being referred for aortic valve replacement surgery because symptoms of aortic stenosis are not being identified or are not attributed to aortic stenosis. As a result, surgery in these patients is frequently delayed or not performed," said Dr. Benjamin H. Freed of the University of Chicago Medical Center, a lead author of the study.

Patients with suspected aortic stenosis should talk to their doctors about whether they need an echocardiogram or other diagnostic tests. Patients with existing aortic stenosis should monitor their conditions carefully and if their conditions become severe, they should discuss their options for aortic valve replacement surgery with their doctors.

STUDY SHOWS DOCTORS CAN BETTER PREDICT SURVIVAL CHANCE FOR HEART PATIENTS WITH NEWER IMAGING TECHNOLOGY

Study finds 3-D echocardiography serves as a stronger predictor of patient outcomes than 2-D

This study showed that physicians can better predict potentially life-threatening cardiac events with real-time, three-dimensional echocardiography technology.

Physicians can use echocardiograms, or heart ultrasound, to view the heart's left ventricular end systolic volume (this measurement refers to the volume of blood in the ventricle immediately after the contraction of the heart) and ejection fraction, (a measurement that determines how well the heart is pumping), which determines the severity of the patient's heart condition. The study concluded that 3-D measurements could help guide management decisions on how to best treat the patient and therefore, better predict the patient's chance of survival.

The American Society of Echocardiography (ASE) is a professional organization of physicians, cardiac sonographers, nurses and scientists involved in echocardiography, the use of ultrasound to image the heart and cardiovascular system. The organization was founded in 1975 and has is the largest international organization for cardiac imaging. For more information on ASE, visit www.asecho.org or ASE's Public Information site, www.SeeMyHeart.org


'/>"/>
SOURCE The American Society of Echocardiography
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Many Heart Attack Patients Dont Get Best Emergency Treatment
2. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
3. American Heart Association Comment Saving Lives in Type 2 Diabetics: Could It Be as Easy as Lowering Blood Pressure?
4. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
5. WorldHeart Announces Further Milestone in Miniaturized Assist Pump Development
6. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
7. Its Only Heartburn...or is it? Chronic Heartburn a Risk Factor for Precursor to Esophageal Cancer
8. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
9. Hypertension: Journal of the American Heart Association Rapid Access Reports: Hispanics Hypertension Better Controlled With Equal Access to Care
10. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
11. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and ... results of its phase 3 EXPEDITION3 trial at the ... meeting. As previously disclosed, solanezumab did not meet the ... of solanezumab initiated in people with mild dementia due ... regulatory submissions for solanezumab for the treatment of mild ...
(Date:12/8/2016)... de dezembro de 2016  A Mederi Therapeutics Inc . anunciou aprovação ... não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto -  ... ... Live Stretta procedure performed and broadcast during the Chinese ... Union Hospital , ...
(Date:12/8/2016)... Pa. , Dec. 8, 2016  Pennsylvania ... Secretary of Drug and Alcohol Programs Gary ... and insomnia medications, known as benzodiazepines, developed with ... "Benzodiazepines are medications that are frequently prescribed ... when they are used with opioid pain medications, ...
Breaking Medicine Technology:
(Date:12/9/2016)... ... December 09, 2016 , ... Sober College, ... with the grand opening of the Sober College Robert Pfeifer Memorial Learning Center ... December 2-3, and was attended by an overwhelming amount of alumni, family, colleagues ...
(Date:12/9/2016)... , ... December 09, 2016 , ... "I had a ... inventor from Winchester, Va. "I thought that if the nebulizer had a more child-friendly ... than fearing them." , He developed the patent-pending NEBY to avoid the need to ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... Franchising Company LLC, announced the first national #QuackGivesBack campaign which supported local ... “This was our first franchise-wide Quack Gives Back initiative, and we’re ...
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, the ... (WIYM) campaign to inform dentists and patients about the safety issues related to dental ... market in the U.S. is projected to reach $6.4 billion in 2018 with more ...
(Date:12/8/2016)... ... 2016 , ... Catalent Pharma Solutions, the leading global provider ... products, today announced that it had joined the Pharmaceutical Supply Chain Initiative (PSCI). ... unite pharmaceutical and healthcare companies that share a vision of better, social, environmental ...
Breaking Medicine News(10 mins):